GENERAL COMMENTS
I cannot understand the results. Both the written and Table reporting are confusing.
This research paper is a cross sectional study of dry eye in a large group of Chinese subjects. They were chosen from a humid and an arid climate. The variables that were studied were symptoms of dry eye, fluorescein BUT and tear flow using Schirmer II. This is an important study because little is known of the prevalence of dry eye in China and its characteristics.
There are many problems with the paper including some that are language related. I trust that this is easily rectified. My biggest problem comes from the lack of clear direction of the study and its process. How were subjects chosen, how were they examined and what were the results. The paper remains confusing to a clinician like me.
I believe that you have a main goal of determining the correlation between signs and symptoms of dry eye. The secondary goals may be the correlation between the 2 signs that were measured, and the importance of the variables of age, sex, location and smoking in dry eye disease. This is important information that should be made clear in the paper.
The following are specific areas that need correction or clarification.
Abstract:
Line 34: PRIMARY OUTCOME MEASURES: please add (Schirmer II) after "amount of tear secretion".
Line 37: RESULTS: The language here is difficult. The "discrepancy" is not defined. The authors should simply say that in this population "there was a significant….. line 38.
In line 39 what do you mean by influencing factors. Were these factors associated with increased signs or symptoms of dry eye?
Line 40-42: This sentence makes little sense to me. Do you mean that Schirmer and BUT did not correlate? If so state this. Do you mean they did not correlate with the group who had no symptoms and with the group who had symptoms?
Line 44-Conclusions: I am not clear about the "pre-clinical phase concept". Do you mean patients who have symptoms of dry eye and yet show no aqueous deficiency or evaporative signs?
Line 45: You must define the "discrepancy patients" clearly.
Line 46-47: use the term break up time.
Line 49: Should read "to our knowledge" this is the first……. syndrome in a large Chinese sample.
Line 51: Please make sure discrepancy is defined for the reader.
Line 53: How did your study show that the questionnaire actually helped. I think that your results show that there are many patients with dry eye symptoms but few with dry eye signs????
Line 56: Do you mean tear osmolarity? Also where do BMI and myocardial infarction fit into this study? I did not read about them in the screening.
Introduction:
Line 76: The world "always" does not apply to dry eye definitions today. Your reference (1) is old and you should use the DEWS 2007 definition here.
Line 77: You are talking about risk factors here and that is the terminology that should be used.
Line 79: If you wish to discuss treatments for dry eye you must include the normal techniques of drops and lid care etc. as well as omrga-3s.
Line 81: Perhaps you can make this sentence clearer by saying "At present, dry eye is often ignored….."
Line 90: The word" lesion" is not appropriate here. Perhaps you can call this a condition or disease or syndrome.
Line 92: The purpose of your study was to determine the lack of correlation between symptoms of dry eye and two tests of dry eye.
Methods:
Line 95: The study was "conducted" between July and August of 2007.
Line 97-98: The Zhuanghe district is located near the Bohai Sea while the Dawa district in inland. The majority of the inhabitants in both districts were farmers. Line 189: You wish to discuss the problem of symptoms versus signs in dry eye disease. You suggest that one of the reasons for this discrepancy is gender. This does not make sense to me. I would like you to tell me how the population that you studied differed by gender in its presentation of symptoms and signs.
Line 198: You wish to discuss the environment and dry eye disease. I think that your choice of populations in very different humidity areas is important here and should be discussed. I would not add the corneal sensitivity information as it does not relate to your study.
Line 207: Why are you discussing workplace use of screens and devices when your population was mainly farmers?
Line 214: You mention a study that showed a lack of correlation between 3 objective dry eye tests: Schirmer versus BUT and staining. You then say that you ALSO found differences between subjective and objective findings. This is not a true comparison.
Line 219: I like the idea of describing a possible progression of dry eye. Line 229: I am assuming that discrepancy subjects are those with signs and no symptoms or symptoms with no signs. What in your study suggests that you must treat these patients? Philosophy is fine but does this relate in any way to your study.
Line 237: The study limitations must be mentioned. The biggest problem is not evaluating the ocular surface or the meibomian glands. I am not sure why you want to add the specific systemic examples of BMI and MI.
Line 246: Are these risk factors obtained from your study? You did have all of these variables in your study but never reported on the location and smoking differences. This is an important paper but it requires a good deal of revision to make it readable. The majority of the inhabitants in both districts were farmers.
VERSION 1 -AUTHOR RESPONSE
Answer: We thank the reviewer for these comments. Yes, we have edited these parts as your suggestions. 20. Line 99: Is it true that the subjects were selected from the official registry by name etc? What were the inclusion and exclusion criteria used for this selection? Was age a factor? Answer: We thank the reviewer for these comments. Yes, the subjects were selected from the official registry by name etc. Age was a factor, and all enrolled subjects aged 12 or older were selected by cluster sampling, and confirmed by door-to-door visitation. Excluding ineligible population owing to death, moving out of the town, nursing, or hospitalization. The subjects who had clear ocular surface disease history such as keratitis or conjunctivitis were excluded. Besides, if these lesions were detected by the slit lamp at the scene, the corresponding subjects were excluded too. We have added this information as your suggestion. 21. Line 102: What does it mean to select randomly? What did the door to door visit confirm? Answer: We thank the reviewer for these comments. There was a misunderstanding for the word "randomly", and actually, all enrolled subjects aged 12 or older were selected by cluster sampling, and inclusion and exclusion were confirmed by door-to-door visitation partially. We thank the reviewer for these comments. Yes, we have edited these parts as your suggestions. In addition, logistic showed that gender (OR = 2.059, p < 0.0001), smoking (OR = 2.263, p < 0.0001) and geographical region (seaside and backland) (OR = 0.272, p < 0.0001) were risk factors for DE subjective symptoms. 37. Line 155: I think this sentence means that 42% of subjects had symptoms and no signs or signs and no symptoms. You might want to say that of the 960 subjects whose signs and symptoms did not correlate, 302 had no symptoms but objective signs and 658 had symptoms and no objective signs. However, I am very unclear about who reported what. Please tell me how many had symptoms, how many had low BUT and how many had low Schrimers and then tell me the correlation of these variables. Answer: We thank the reviewer for these comments. Yes, we have edited these parts as your suggestions." Of the 2262 subjects, 1710 subjects had symptoms and 1354 subjects had low BUT and Schrimers. Additionally, the discrepancy contained 960 subjects (42.44%) with significant difference (χ2=4.027, p = 0.045＜0.05) ( Table 2 )." 38. Line 157: I do not understand the significant difference in the two cohorts. Which cohorts are we talking about? I do not understand Table 2 . Answer: We thank the reviewer for these comments. The two cohorts were referred to the discrepancy group and others. There was a misunderstanding of "cohorts". We have edited these parts as your suggestions. We thank the reviewer for these comments. Age was not a risk factor for DE symptoms in all enrolled subjects, and the subjects with the disagreement between the occurrence of symptoms and clinical findings, was regarded to the discrepancy. We have added this information in the paper. 47. Line 229: I am assuming that discrepancy subjects are those with signs and no symptoms or symptoms with no signs. What in your study suggests that you must treat these patients? Philosophy is fine but does this relate in any way to your study. Answer: We thank the reviewer for these comments. As therapy strategies, we need to treat both signs and symptoms of the discrepancy subjects, because in this stage, Schirmer II test and BUT have already decreased, compared with the normal subjects in the present study. But we often ignore these conditions in clinics, due to the lack of symptoms or clinical findings. We have added this information as your suggestion. 48. Line 237: The study limitations must be mentioned. The biggest problem is not evaluating the ocular surface or the meibomian glands. I am not sure why you want to add the specific systemic examples of BMI and MI. Answer: We thank the reviewer for these comments. Yes, we have added this problem and deleted BMI and MI as your suggestion. 49. Line 246: Are these risk factors obtained from your study? You did have all of these variables in your study but never reported on the location and smoking differences. Answer: We thank the reviewer for these comments. Yes, these risk factors are obtained from this study, and we found that smoking (OR = 2.263, p < 0.0001) and geographical region (seaside and backland) (OR = 0.272, p < 0.0001) were risk factors for DE subjective symptoms. In addition, the environmental conditions of dry locations need to be improved or the tear film should be protected against adverse environmental conditions (Abusharha AA, Pearce EI. Line 50-these comments belong in the Discussion.
Introduction
Line82-87-I would leave out the information of subjective symptoms and the treatment sentences.
Line 97-Although there are many population based survey studies of dry eye in the world, there are few in China. Therefore we conducted….
Line 101. add "Secondarily we and analyzed the association of smoking and humidity in dry eye."
Methods:
Line 112-How were the questionnaires distributed? Line 125-does this mean that they came to the clinic to do the questionnaire or was it done at home?
Line 148-We used standardized slit lamps at all visits.
Line159-I think that you mean that the subjects were asked to blink normally.
Line161-Do you need both test scores to be positive or just one?
Line 167-geographical sp Line 178-Schirmers sp Line 179-I think you are saying that 960 of the total population who had a positive symptoms score but negative BUT and/or Schirmer or the opposite. What is the statistical analysis here? I think you want to erase the Chi squared data and Table 2 .
Line 183-I do not understand this sentence. What do you mean by positive or negative?
Line 185-What do you mean by the ratio of subjects to symptoms? What is the accuracy of subject to disease? Do you mean that those who had no symptoms but had signs? Please make this section clear to the reader.
Line 196-Please use the word percentage and not number.
Line 199-You have not yet defined the "normal" group. Please do so somewhere.
Line200-I think your groups add up to all your subects so you might just say that.
Discussion:
Line 207 ..components include meibomian….
Line 211-I think you should limit your discussion of tear osmolarity as it is not a part of this paper. Just talk briefly about it as impractical for your study. Line 224-Here you are discussing BUT and its clinical usage and the difference compared to symptoms. You state the findings in your study and you should then recognize that symptoms do not correlate well with BUT and therefore clinically you have learned to do both. That is important in your study.
Line 236-I do not see how sex differences in symptoms tells us why there are differences between signs and symptoms. I would include this information only to say that your findings agree with the Cia study and that female sex is a risk factor for DE.
Line249-This is an important part of the discussion but seems long. I would summarize the points relating to regional humidity and simply mention the indoor environmental studies briefly.
Line 282-The issue of signs and symptoms not correlating is not uncommon in many disease including g headache and autoimmune disease. Having a combination of tests and set criteria for diagnosis and differentiation is an important part of the ongoing research in dry eye. So I would make this point strongly.
Line 292-Then comes the idea that you have determined a progress of the disease. In fact you have not. You have done a crosssectional study and recorded your findings. That is as far as you can go. You might suggest a future longitudinal study in which you follow the symptomless and see what happens.
Line 300-here you state that age is not a risk factor for DE but later you say that it is. Please clarify.
Line303-I would not g into treatment here as it does not apply to this study. 10. Line 112-How were the questionnaires distributed? Answer: We thank the reviewer for these great comments. The questionnaires were distributed by the investigators, during the initial home visit and previously, the investigators should identify the enrolled subjects according the standard in the present study. We have edited this part per your suggestions. 11. Line 125-does this mean that they came to the clinic to do the questionnaire or was it done at home? Answer: We thank the reviewer for these great comments. The subjects do the questionnaire at home. And "After answering a self-administered questionnaire distributed by the investigators, all of the eligible subjects from the same community were then brought to a central location for clinical investigation." We have edited this part per your suggestions. 12. Line 148-We used standardized slit lamps at all visits. Answer: We thank the reviewer for these great comments. We have edited this part per your suggestions. 13. Line159-I think that you mean that the subjects were asked to blink normally. Answer: We thank the reviewer for these great comments. Yes and we have edited this part according to your suggestions. 14. Line161-Do you need both test scores to be positive or just one? Answer: We thank the reviewer for these great comments. We need both test scores to be positive. 24. Line 211-I think you should limit your discussion of tear osmolarity as it is not a part of this paper.
Just talk briefly about it as impractical for your study. Answer: We thank the reviewer for these great comments, and we have edited this part according to your suggestions. 25. Line 224-Here you are discussing BUT and its clinical usage and the difference compared to symptoms. You state the findings in your study and you should then recognize that symptoms do not correlate well with BUT and therefore clinically you have learned to do both. That is important in your study. Answer: We thank the reviewer for these great comments, and we have edited this part according to your suggestions. 26. Line 236-I do not see how sex differences in symptoms tells us why there are differences between signs and symptoms. I would include this information only to say that your findings agree with the Cia study and that female sex is a risk factor for DE. Answer: We thank the reviewer for these great comments, and we have edited this part according to your suggestions. In the present study, gender (OR = 2.059, p < 0.0001) was a risk factor for subjectively reported DE symptoms. Moreover, of the 1354 subjects with positive clinical findings, 622 out of 780 (87.12%) female subjects presented with related symptoms, while 390 of 574 (89.51%) males presented with related symptoms. Compared with males, females were more likely to experience symptoms of DE (χ2=12.193, p < 0.0001) . 27. Line249-This is an important part of the discussion but seems long. I would summarize the points relating to regional humidity and simply mention the indoor environmental studies briefly. Answer: We thank the reviewer for these great comments, and we have edited this part according to your suggestions. 28. Line 282-The issue of signs and symptoms not correlating is not uncommon in many disease including g headache and autoimmune disease. Having a combination of tests and set criteria for diagnosis and differentiation is an important part of the ongoing research in dry eye. So I would make this point strongly. Answer: We thank the reviewer for these great comments, and we have edited this part according to your suggestions. The lack of correlation between objective clinical findings and subjective symptomatic reporting is not an uncommon one. For example, early detection of glaucoma is often difficult as it is frequently asymptomatic during the initial stages of the disease. Thus, studies have shown that the majority of glaucoma cases are not diagnosed until later stage disease progression has occurred. 29. Line 292-Then comes the idea that you have determined a progress of the disease. In fact you have not. You have done a cross-sectional study and recorded your findings. That is as far as you can go. You might suggest a future longitudinal study in which you follow the symptomless and see what happens. Answer: We thank the reviewer for these great comments, and we have mentioned that future longitudinal studies will be necessary to follow DE lesion progression in asymptomatic subjects, according to your suggestions. Actually, this was a cross sectional investigation. So we just ranked and classified the subjects according to the severity of the reduction in tear secretion and tear film BUT values. We did not determine a progress of the disease in this study. 30. Line 300-here you state that age is not a risk factor for DE but later you say that it is. Please clarify.
